Renal replacement therapy in cryoglobulinaemic nephritis.
Seventeen patients with nephritis due to mixed cryoglobulinaemia were submitted to regular haemodialysis in 11 and continuous ambulatory peritoneal dialysis in six after 145 +/- 55 months from the onset of the disease. Four patients with very poor clinical conditions died within 6 months from the beginning of dialysis. The other 13 patients were followed for a mean period of 78.7 +/- 41.6 months. The actuarial survival rate was 65% at 5 years. Both clinical and immunological signs of mixed cryoglobulinaemia reduced during dialysis but a long-lasting burn out was observed only in one patient. Two patients received a kidney graft. Mixed cryoglobulinaemia nephritis recurred in both of them respectively 5 and 10 months after transplantation. One patient lost his graft 13 months after transplantation because of chronic rejection. The other one still has a functioning kidney 48 months after renal transplantation. The life expectancy with dialysis for mixed cryoglobulinaemia patients is similar to that of patients with standard primary renal disease but some few patients with severe disease at the beginning of dialysis have a poor prognosis. Nephritis may recur after renal transplantation but this does not preclude per se a favourable course in the long term.
Tarantino
A
A
Division of Nephrology, Ospedale Maggiore IRCCS, Milano, Italy.
Moroni
G
G
Banfi
G
G
Manzoni
C
C
Segagni
S
S
Ponticelli
C
C
D000206:Actuarial Analysis; D000328:Adult; D000368:Aged; D003449:Cryoglobulinemia / Q000150:complications*; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009393:Nephritis / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011379:Prognosis; D012008:Recurrence; D006435:Renal Dialysis; D017582:Renal Replacement Therapy; D016019:Survival Analysis; D016896:Treatment Outcome